Facebook pixel

Frequently Asked Questions

frequently asked questions, faq
Our Frequently Asked Questions (FAQs) for Pseudomyxoma Peritonei (PMP) and Appendix Cancers. PMP is a rare cancer that affects the abdominal cavity, while appendix cancer is a malignancy that arises from the cells of the appendix. Both types of cancer can be difficult to diagnose and treat due to their rarity and complex nature. On this page, we have compiled a list of frequently asked questions related to PMP and appendix cancers to help provide you with information and resources on these conditions. Our aim is to provide answers to some of the most common questions and concerns related to PMP and appendix cancers, and to offer support and guidance for those affected by these rare diseases.

If you have any Frequently Asked Questions to add, let us know.

What is adenocarcinoma ex-goblet cell?

Adenocarcinoma Ex-Goblet Cell of the appendix is a type of cancer that originates from the cells that line the inside of the appendix.

What is goblet cell adencarcinoma

Goblet cell adenocarcinoma is a rare type of cancer that arises from cells that are normally present in the lining of the appendix.

Is pseudomyxoma peritonei a cancer?

Yes, pseudomyxoma peritonei (PMP) is a rare cancer that usually starts in the appendix and can spread to the peritoneum, which is the lining of the abdominal cavity.

What are some of the factors that can impact the prognosis for PMP?

There are several factors that can impact the prognosis for Pseudomyxoma peritonei (PMP), including the histological grade of the tumour

Is cancer of the appendix genetic?

Is cancer of the appendix genetic?

A recent study in JAMA Oncology revealed that around 10% of individuals diagnosed with appendiceal cancer have an inherited genetic variant that increases their risk for cancer predisposition. This is the first study to identify inherited risk factors for this uncommon type of cancer.

read more
What is the PCI score?

What is the PCI score?

Doctors use the PCI score to help guide treatment options for Pseudomyxoma Peritonei (PMP) and other cancers that affect the lining of the abdomen.

read more
Should I have CRS/HIPEC?

Should I have CRS/HIPEC?

The decision to undergo cytoreductive surgery with HIPEC for pseudomyxoma peritonei (PMP) is a personal one and should be made in consultation with your medical team.

read more